Catalyst Pharmaceuticals, Inc. (CPRX)
31.28
-0.04
(-0.14%)
USD |
NASDAQ |
May 27, 13:06
Catalyst Pharmaceuticals Cash from Investing (Quarterly) : -0.027M for March 31, 2026
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| ADMA Biologics, Inc. | 2.404M |
| Inovio Pharmaceuticals, Inc. | 2.636M |
| United Therapeutics Corp. | 743.70M |
| Regeneron Pharmaceuticals, Inc. | -428.90M |
| Agios Pharmaceuticals, Inc. | 141.31M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | 59.59M |
| Cash from Financing (Quarterly) | -12.87M |
| Free Cash Flow | 208.13M |
| Free Cash Flow Per Share (Quarterly) | 0.4693 |
| Free Cash Flow to Equity (Quarterly) | 59.67M |
| Free Cash Flow to Firm (Quarterly) | 59.56M |
| Free Cash Flow Yield | 5.23% |